Screener
Allogene Therapeutics ALLO Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from Allogene Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Allogene Therapeutics’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-034585
FAQ
- What is Allogene Therapeutics's book value per share?
- Allogene Therapeutics (ALLO) reported book value per share of $1.16 in Q1 2026.
- How has Allogene Therapeutics's book value per share changed year-over-year?
- Allogene Therapeutics's book value per share decreased by 35.1% year-over-year, from $1.79 to $1.16.
- What is the long-term trend for Allogene Therapeutics's book value per share?
- Over 5 years (2020 to 2025), Allogene Therapeutics's book value per share has grown at a -30.9% compound annual growth rate (CAGR), from $8.42 to $1.33.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.
Ask your AI about Allogene Therapeutics's book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude